October 11, 2017 | Swiss pharma and biotech supplier Lonza announced it will establish an innovation center in Haifa Economic Corporation’s life sciences park. The 1,000 square meter Lonza Collaborative Innovation Center will begin operating by the end of 2017. Fifteen to 20 researchers are expected to be working there in 2018. Lonza plans to use the center to accelerate its R&D projects in its pharma and biotech divisions, while gaining exposure to Israel’s strengths in engineering, molecular biology, cellular biology, software, and tech. Lonza has already signed a memorandum of understanding with each schools like Tel Aviv University, Technion – Israel Institute of Technology, and Weizmann Institute of Science and has begun conducting an initial survey to find breakthrough technologies. The Basel, Switzerland-based Lonza Group supplies products and services to pharmaceutical and agrochemical industries.